An autopsy case of Trousseau’s syndrome with tumor thrombosis in unknown primary squamous cell carcinoma of the head and neck

被引:0
作者
Kensuke Uraguchi
Kenichi Kozakura
Maki Fukuda
Hidenori Marunaka
Akira Doi
Tsuyoshi Ohta
Jun Iwata
Shin Kariya
机构
[1] Okayama University Graduate School of Medicine,Department of Otolaryngology
[2] Dentistry and Pharmaceutical Sciences,Head and Neck Surgery
[3] Kochi Health Sciences Center,Department of Otorhinolaryngology
[4] Kochi Health Sciences Center,Department of Neurosurgery
[5] Kochi Health Sciences Center,Department of Pathology
来源
International Cancer Conference Journal | 2021年 / 10卷
关键词
Trousseau’s syndrome; Tumor thrombosis; Cancer-associated thrombosis; Carcinoma of unknown primary; Squamous cell carcinoma;
D O I
暂无
中图分类号
学科分类号
摘要
Trousseau’s syndrome (TS) and tumor thrombosis (TT) are known as cancer-associated thrombosis with poor prognosis. TS is extremely rare in patients with squamous cell carcinoma. In this study, we report an unknown primary squamous cell carcinoma of the head and neck (SCCHN) patient with TS and TT in pulmonary artery definitely diagnosed by autopsy. A 73-year-old man had a past surgical history for unknown primary SCCHN and lung metastases. Three years after the initial surgery, the patient had multiple cerebral infarction, deep venous thrombosis in the legs and mediastinum metastases. Our diagnosis was TS and treatment with chemotherapy and unfractionated molecular heparin started. It could help control the hypercoagulative state and cancer progression, but finally, he died from progressive disease (mediastinum metastases and pulmonary embolism) five years after the initial surgery. An autopsy revealed multiple metastases and thrombosis in the pulmonary artery with squamous cell carcinoma microscopically. Although there is no established treatment for managing TS, intensive therapy such as a combination of chemotherapy and anticoagulant therapy can be effective in improving hypercoagulation therapy. In addition, an autopsy should be considered for patients with thrombosis to distinguish between TS and TT.
引用
收藏
页码:15 / 19
页数:4
相关论文
共 62 条
  • [1] Trousseau A(1865)Phlegmasia alba dolens. Clinique Medicale de l’Hôtel-Dieu de Paris London New Sydenham Soc 3 654-712
  • [2] Toyonaga H(2017)Pulmonary tumor thrombotic microangiopathy caused by a parotid tumor: early antemortem diagnosis and long-term survival Intern Med 56 67-71
  • [3] Tsuchiya M(2019)Trousseau syndrome in a patient with advanced oral squamous cell carcinoma: a case report J Med Case Res 13 26-97
  • [4] Sakaguchi C(2013)Cancer-related coagulopathy (Trousseau’s syndrome): review of the literature and experience of a single center of internal medicine Clin Exp Med 13 85-2030
  • [5] Aoyama KI(2004)Stroke in patients with cancer: incidence and etiology Neurology 62 2025-1729
  • [6] Tamura M(2007)Trousseau's syndrome: multiple definitions and multiple mechanisms Blood 110 1723-235
  • [7] Uchibori M(2012)A nation-wide analysis of venous thromboembolism in 497,180 cancer patients with the development and validation of a risk-stratification scoring system Thromb Haemost 108 225-1323
  • [8] Dammacco F(2013)Pulmonary tumor thrombotic microangiopathy: a clinical analysis of 30 autopsy cases Intern Med 52 1317-906
  • [9] Vacca A(2019)Cardiac metastasis in a living patient with oral cancer Auris Nasus Larynx 46 902-S177
  • [10] Procaccio P(2017)Tumor thrombus: incidence, imaging, prognosis and treatment Cardiovasc Diagn Ther 7 S165-208